Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation-Reference-Cited by-同舟云学术

Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation

Published:2013-06-06 Issue:3 Volume:37 Page:233-239
ISSN:1383-875X
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Haines David E.,Mead-Salley Michelle,Salazar Miguel,Marchlinski Francis E.,Zado Erica,Calkins Hugh,Yarmohammadi Hirad,Nademanee Koonlawee,Amnueypol Montawatt,Skanes Allan C.,Saklani Pradyot

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10840-013-9800-z.pdf

Reference28 articles.

1. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2012; 9:632–696.

2. Sorgente, A., Chierchia, G. B., de Asmundis, C., Sarkozy, A., Capulzini, L., & Brugada, P. (2011). Complications of atrial fibrillation ablation: when prevention is better than cure. Europace, 13, 1526–1532.

3. Bohnen, M., Stevenson, W. G., Tedrow, U. B., Michaud, G. F., John, R. M., Epstein, L. M., et al. (2011). Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm, 8, 1661–1666.

4. Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3, 32–38.

5. Oral, H., Chugh, A., Ozaydin, M., Good, E., Fortino, J., Sankaran, S., et al. (2006). Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation, 114, 759–765.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation;JACC: Clinical Electrophysiology;2019-12

2. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis;Cardiovascular Therapeutics;2018-07-30

3. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials;EP Europace;2018-06-29

4. Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives;Expert Opinion on Drug Safety;2017-06-15

5. Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation;Clinical Cardiology;2017-05-31